Atropine Sulfate Injection, USP, is indicated for temporary blockade of severe or life threatening muscarinic effects, e.g., as an antisialagogue, an antivagal agent, an antidote for organophosphorus or muscarinic mushroom poisoning, and to treat bradyasystolic cardiac arrest. Atropine is a muscarinic antagonist indicated for temporary blockade of severe or life threatening muscarinic effects.
From the U.S. FDA-approved label for Atropine. Full label: DailyMed.
Atropine Sulfate Injection, USP, is indicated for temporary blockade of severe or life threatening muscarinic effects, e.g., as an antisialagogue, an antivagal agent, an antidote for organophosphorus or muscarinic mushroom poisoning, and to treat bradyasystolic cardiac arrest. Atropine is a muscarinic antagonist indicated for temporary blockade of severe or life threatening muscarinic effects.
From the U.S. FDA-approved label for Atropine. Full label: DailyMed.
For intravenous administration.. Titrate according to heart rate, PR interval, blood pressure and symptoms. Adult dosage Antisialagogue or for antivagal effects: Initial single dose of 0.5 to 1 mg.
Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.
Tachycardia Glaucoma Pyloric obstruction Worsening urinary retention Viscid bronchial plugs 5.1 Tachycardia When the recurrent use of atropine is essential in patients with coronary artery disease, the total dose should be restricted to 2 to 3 mg (maximum 0.03 to 0.04 mg/kg) to avoid the detrimental effects of atropine-induced tachycardia on myocardial oxygen demand. 5.2 Acute Glaucoma Atropine may precipitate acute glaucoma. 5.3 Pyloric Obstruction Atropine may convert partial organic pyloric stenosis into complete obstruction.
Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.
The following adverse reactions have been identified during post-approval use of atropine sulfate. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. Most of the side effects of atropine are directly related to its antimuscarinic action.
Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.
49 products from 34 makers in the NepalDoc medicine catalog use this generic:
| Brand | Composition | Maker | Pack |
|---|---|---|---|
| Ataron Eye Drop | Atropine (1% w/v) | Cipla Ltd | packet of 5 ml Eye Drop |
| Atover 0.6mg Injection | Atropine (0.6mg) | Verve Formulations Pvt Ltd | vial of 1 ml Injection |
| Atp 0.6mg Injection | Atropine (0.6mg) | Biomiicron Pharmaceuticals | vial of 1 ml Injection |
| Atpine Eye Drop | Atropine (1% w/v) | Search Orbis Pharmaceuticals | packet of 5 ml Eye Drop |
| Atrapar 0.6mg Injection | Atropine (0.6mg) | Biomedica International | vial of 10 ml Injection |
| Atrapar Eye Drop | Atropine (1% w/w) | Biomedica International | bottle of 5 ml Eye Drop |
| Atro Eye Drop | Atropine (1% w/v) | Intas Pharmaceuticals Ltd | packet of 5 ml Eye Drop |
| Atro Injection | Atropine (NA) | Laborate Pharmaceuticals India Ltd | vial of 1 ml Injection |
| Atromet Eye Drop | Atropine (1% w/v) | Sun Pharmaceutical Industries Ltd | packet of 5 ml Eye Drop |
| Atrone 1% Eye Drop | Atropine (1% w/v) | Vision Pharma | bottle of 5 ml Eye Drop |
| Atronex 0.6mg Injection | Atropine (0.6mg) | Indus Pharma Pvt Ltd | vial of 1 ml Injection |
| Atronir Injection | Atropine (NA) | Nirlife Healthcare | vial of 1 ml Injection |
| Atrop Eye Drop | Atropine (1% w/v) | Aurolab | bottle of 5 ml Eye Drop |
| Atropa 0.6mg Injection | Atropine (0.6mg) | Troikaa Pharmaceuticals Ltd | vial of 1 ml Injection |
| Atroped 0.01% Eye Drop | Atropine (0.01% w/v) | Sunways India Pvt Ltd | bottle of 5 ml Eye Drop |
| Atropin Infusion | Atropine (0.6mg) | Venus Remedies Ltd | bottle of 100 ml Infusion |
| Atropin Injection | Atropine (NA) | Hindustan Syringes & Medical Devices Ltd | vial of 1 ml Injection |
| Atropine 1% Eye Drop | Atropine (1% w/v) | Pharmatak Opthalmics Pvt Ltd | packet of 5 ml Eye Drop |
| Atropine Eye Ointment | Atropine (1% w/w) | Jawa Pharmaceuticals Pvt Ltd | tube of 5 gm Eye Ointment |
| Atropine Sulphate 0.6mg Infusion | Atropine (0.6mg) | Samarth Life Sciences Pvt Ltd | bottle of 50 ml Infusion |
| Atropine Sulphate 1% Eye Ointment | Atropine (1% w/w) | Pharmatak Opthalmics Pvt Ltd | tube of 3 gm Eye Ointment |
| Atrosulph Eye Drop | Atropine (1% w/v) | Entod Pharmaceuticals Ltd | packet of 5 ml Eye Drop |
| Atrosun Eye Drop | Atropine (1% w/v) | Sunways India Pvt Ltd | packet of 3 ml Eye Drop |
| Atrosun Eye Ointment | Atropine (1% w/w) | Sunways India Pvt Ltd | tube of 3 gm Eye Ointment |
| Atrowok 0.6mg Injection | Atropine (0.6mg) | Wockhardt Ltd | vial of 1 ml Injection |
| Bell Mfc Eye Drop | Atropine (1% w/v) | Bell Pharma Pvt Ltd | packet of 5 ml Eye Drop |
| Bell Pino Atrin Eye Drop | Atropine (1% w/v) | Bell Pharma Pvt Ltd | packet of 10 ml Eye Drop |
| Bell Pino Atrin Eye Ointment | Atropine (1% w/w) | Bell Pharma Pvt Ltd | tube of 3 gm Eye Ointment |
| Bysipin Eye Drops | Atropine (0.01% w/v) | Neomedix Healthcare India Private Limited | bottle of 5 ml Ophthalmic Solution |
| Kidtro Eye Drop | Atropine (0.01% w/v) | Sun Pharmaceutical Industries Ltd | bottle of 5 ml Ophthalmic Solution |
Showing 30 of 49 catalog products. Search the full catalog in the app.
Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.
Store at 20°C to 25°C (68°F to 77°F);
Storage information from the U.S. FDA-approved label.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. NLEM listing does not guarantee that a medicine is in stock at any pharmacy.
